The ISoP Clinical Pharmacometrics Special Interest Group in collaboration with ACCP recently released a white paper highlighting the need for greater exposure-based drug labeling to reduce the widespread and risky practice of off-label dosing. Such a pharmacometric approach to prescribing can improve the care and treatment of individual patients. You can read the whitepaper by clicking here.
+1-908-253-3608